University of Minnesota researchers’ study of “exceptional responders” led to the identification of a new drug target for brain cancer

In light of the COVID-19 pandemic and calls for social justice across the globe, the Office of Curriculum, Assessment and Evaluation on the Duluth Campus reflect on their collaborations with medical students for education reform. 

New research from the laboratory of Peter B. Kang, MD, found mutations in a novel gene that may help identify patients with a specific form of muscular dystrophy.